iSAM Funds UK Ltd Makes New Investment in The Chemours Company (NYSE:CC)

iSAM Funds UK Ltd purchased a new position in The Chemours Company (NYSE:CC) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 19,657 shares of the specialty chemicals company’s stock, valued at approximately $332,000.

Other institutional investors have also added to or reduced their stakes in the company. Quadrant Capital Group LLC raised its stake in shares of Chemours by 100.4% in the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 1,119 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new position in shares of Chemours in the fourth quarter worth about $48,000. Itau Unibanco Holding S.A. raised its stake in shares of Chemours by 39.3% in the fourth quarter. Itau Unibanco Holding S.A. now owns 3,554 shares of the specialty chemicals company’s stock worth $60,000 after purchasing an additional 1,003 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Chemours in the fourth quarter worth about $91,000. Finally, KBC Group NV raised its stake in shares of Chemours by 38.2% in the fourth quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company’s stock worth $104,000 after purchasing an additional 1,708 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours Stock Down 0.1%

Chemours stock opened at $11.17 on Wednesday. The stock has a market capitalization of $1.67 billion, a PE ratio of 19.60 and a beta of 1.76. The Chemours Company has a 12 month low of $9.33 and a 12 month high of $28.86. The business has a 50 day simple moving average of $12.21 and a 200-day simple moving average of $16.19. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92.

Chemours (NYSE:CC) last posted its quarterly earnings data on Tuesday, May 6th. The specialty chemicals company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). The business had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The firm’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.32 earnings per share. On average, analysts anticipate that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Announces Dividend

The firm also recently disclosed a dividend, which will be paid on Monday, June 16th. Stockholders of record on Monday, May 19th will be given a $0.0875 dividend. This represents a dividend yield of 3.17%. The ex-dividend date of this dividend is Friday, May 16th. Chemours’s dividend payout ratio (DPR) is presently 175.00%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Mizuho set a $15.00 price target on Chemours in a research report on Tuesday, April 15th. Barclays reduced their price target on Chemours from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 1st. Royal Bank of Canada reduced their price target on Chemours from $17.00 to $14.00 and set an “outperform” rating for the company in a research report on Thursday, May 8th. Truist Financial reduced their price target on Chemours from $27.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, April 14th. Finally, BMO Capital Markets reduced their price target on Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Chemours currently has a consensus rating of “Hold” and an average price target of $17.56.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.